IMA has a higher rate of ALK rearrangement mutations (2.2%) and a lower rate of EGFR mutations (0–5%) than nonmucinous adenocarcinoma of the lung [47–49]. The gene discussed is EGFR; the disease is lung adenocarcinoma.